How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
Study Design — ATTACC-CAP
REMAP-CAP
Presentations — ATTACC-CAP
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research
ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial - The Lancet Oncology
REMAP-CAP • Coronavirus
CAP - Trial Practice, Second Edition (9780769855332). Authors: Michael Martin, Paul Radvany, Lawrence Dubin, Thomas F. Guernsey. Carolina Academic Press
Celebrating REMAP – CAPs success on International Clinical Trials Day – ACTA – Australian Clinical Trials Alliance
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial - The Lancet Oncology
REMAP-CAP - Combacte
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
Media — REMAP-CAP Trial
ProtecT and CAP trial recruitment phases and endpoint assessment... | Download Scientific Diagram
Background — REMAP-CAP Trial
HOPE-3 trial of DMD therapy CAP-1002 to continue as planned
REMAP-CAP – The Bottom Line
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 4 (2020)
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial | Circulation: Cardiovascular Interventions
Momentum 3 Trial - CAP Publication | Abbott
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP- COVID) - Sunnybrook Research Institute
High dose vitamin C 'ineffective' in treating Covid-19, but statin beneficial | NIHR
